Decentralized Clinical Trials in Rare Diseases: Opportunities and Risks
Decentralized Clinical Trials in Rare Diseases: Opportunities and Risks Harnessing Decentralized Clinical Trials to Improve Access in Rare Disease Research The Rationale for Decentralization in Rare Disease Trials Rare disease trials face one central challenge: patient scarcity scattered across vast geographies. Traditional site-based clinical trials often fail to recruit sufficient participants due to travel limitations,…
Read More “Decentralized Clinical Trials in Rare Diseases: Opportunities and Risks” »
